Anavex Life Sciences Corp (AVXL)

[Citrati]

Trials cost money. Potential partners always look to make the cheapest deal possible. They reduce front end payments and royalty payments by saying you can't get there without us and use their capital availability as a bargaining chip (sledge hammer).
Often the entity with potential product files an S-3 to be able to turn around and then say "be fair" and pay proper value or we will do it ourselves and wait for better terms from someone else.
High stakes bio chess.

Just one option of many for doing the S-3 now.
All IMO only.
AVXL